Clinical Trial Update: The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating cilostazol as an adjunct to conventional therapy for osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Sadat City University | Conditions: Osteoarthritis | Phase 1, Phase 2 | Status: WITHDRAWN